You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Anti-eIF4G1 (phospho S1108) antibody (ab4772)

CodeSizePriceAbpointsAvailability
    
 
  • -

  •   
  •   
  •   
  •  

  •  
  •  
  •  

  •  
Updating...

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »

Overview

Product name

Anti-eIF4G1 (phospho S1108) antibody
See all eIF4G1 products (11) ...

Description

Rabbit polyclonal to eIF4G1 (phospho S1108)

Tested applications

WBmore details

Cross reactivity

Reacts with

Human

Predicted to work with

Rabbit

Immunogen

Synthetic peptide (Human) derived from the region of human eIF-4G that contains serine 1108.

Positive control

Hek293 cells.

Properties

Form

Liquid

Storage instructions

Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.

Storage buffer

Preservative: 0.05% Sodium Azide
Constituents: 50% Glycerol, Dulbecco's phosphate buffered saline (without Mg2+ and Ca2+), 1mg/ml BSA (IgG, protease free) as a carrier. pH 7.3

Concentration

Concentration information loading...

Purity

Immunogen affinity purified

Purification notes

Purified from rabbit serum by sequential epitope-specific chromatography. The antibody has been negatively preadsorbed using a non-phosphopeptide corresponding to the site of phosphorylation to remove antibody that is reactive with non-phosphorylated eIF-4G. The final product is generated by affinity chromatography using a eIF-4G derived peptide that is phosphorylated at serine 1108.

Clonality

Polyclonal

Isotype

IgG

  • Western blot - eIF4G1 (phospho S1108) antibody (ab4772)Western blot - eIF4G1 (phospho S1108) antibody (ab4772) image (enlarge)

Applications

Show applications key

Our Abpromise guarantee covers the use of ab4772 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Target

Function

Component of the protein complex eIF4F, which is involved in the recognition of the mRNA cap, ATP-dependent unwinding of 5'-terminal secondary structure and recruitment of mRNA to the ribosome.

Involvement in disease

Defects in EIF4G1 are the cause of Parkinson disease type 18 (PARK18) [MIM:614251]. An autosomal dominant, late-onset form of Parkinson disease. Parkinson disease is a complex neurodegenerative disorder characterized by bradykinesia, resting tremor, muscular rigidity and postural instability, as well as by a clinically significant response to treatment with levodopa. The pathology involves the loss of dopaminergic neurons in the substantia nigra and the presence of Lewy bodies (intraneuronal accumulations of aggregated proteins), in surviving neurons in various areas of the brain.

Sequence similarities

Belongs to the eIF4G family.
Contains 1 MI domain.
Contains 1 MIF4G domain.
Contains 1 W2 domain.

Post-translational
modifications

Phosphorylated at multiple sites in vivo. Phosphorylation at Ser-1185 by PRKCA induces binding to MKNK1.
Following infection by certain enteroviruses, rhinoviruses and aphthoviruses, EIF4G1 is cleaved by the viral protease 2A, or the leader protease in the case of aphthoviruses. This shuts down the capped cellular mRNA transcription.

Target information above from: UniProt accessionQ04637 The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).

Information by UniProt

Alternative names

  • DKFZp686A1451 antibody
  • eIF 4 gamma 1 antibody
  • eIF 4G 1 antibody
  • eIF 4G1 antibody
  • eIF-4-gamma 1 antibody
  • eIF-4G 1 antibody
  • eIF-4G1 antibody
  • EIF4 gamma antibody
  • EIF4F antibody
  • EIF4G antibody
  • EIF4G1 antibody
  • EIF4GI antibody
  • Eukaryotic translation initiation factor 4 gamma 1 antibody
  • IF4G1_HUMAN antibody
  • p220 antibody
see all

Anti-eIF4G1 (phospho S1108) antibody images:

  Western blot - eIF4G1 (phospho S1108) antibody (ab4772)

Western blot - eIF4G1 (phospho S1108) antibody (ab4772)



Predicted band size : 200 kDa


Peptide Competition: Extracts prepared from Hek293 cells were resolved on a 10% polyacrylamide gel and transferred to PVDF. Membranes were either treated with lambda phosphatase (5) or untreated (1-4, 6), were blocked with a 3% non-fat milk-TBST buffer overnight at 4oC, then were incubated with 1.0 µg/mL ab4772 antibody for two hours at room temperature in a 3% non-fat milk-TBST buffer, following its prior incubation with the phosphopeptide immunogen (1), no peptide (2, 5, 6), the non phosphopeptide corresponding to the immunogen (3), or, a generic phosphoserine containing peptide (4). After washing, membranes were incubated with goat F(ab')2 anti-rabbit IgG alkaline phosphatase and the signal was detected using the Tropix WesternStar method. The data show that only the phosphopeptide corresponding to ab4772 blocks the antibody signal, demonstrating the specificity of the antibody. The data also show that phosphatase treatment eliminates the signal, verifying that the antibody is phosphospecific.

References for Anti-eIF4G1 (phospho S1108) antibody (ab4772)

ab4772 has not yet been referenced specifically in any publications.

Publishing research using ab4772? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"